{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:18Z","timestamp":1759104198251,"version":"3.44.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Tisch Multiple Sclerosis Research Center of New York"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.jneuroim.2013.05.009","type":"journal-article","created":{"date-parts":[[2013,6,22]],"date-time":"2013-06-22T03:00:19Z","timestamp":1371870019000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab"],"prefix":"10.1016","volume":"261","author":[{"given":"Jerry","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peggy","family":"Bettin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saud A.","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2013.05.009_bb0005","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/jnnp.61.4.339","article-title":"The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: a consensus report. The EU Concerted Action on Virus Meningitis and Encephalitis","volume":"61","author":"Cinque","year":"1996","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0015","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0020","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/jmv.21313","article-title":"Presence and expression of JCV early gene large T Antigen in the brains of immunocompromised and immunocompetent individuals","volume":"80","author":"Delbue","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC virus antibodies: implications for PML risk stratification","volume":"68","author":"Gorelik","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0030","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jneuroim.2007.04.002","article-title":"Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: discrimination between microorganism-driven and polyspecific immune response","volume":"187","author":"Jacobi","year":"2007","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0035","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s11481-012-9366-z","article-title":"Urinary JCV-DNA testing during natalizumab treatment may increase accuracy of PML risk stratification","volume":"7","author":"Laroni","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0040","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00415-009-5296-y","article-title":"Intrathecal antibody production against Epstein-Barr and other neurotropic viruses in pediatric and adult onset multiple sclerosis","volume":"257","author":"Pohl","year":"2010","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0045","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1056\/NEJMoa044397","article-title":"A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis","volume":"354","author":"Polman","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.22107","article-title":"Assessment of JC virus DNA in blood and urine from natalizumab-treated patients","volume":"68","author":"Rudick","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0055","series-title":"Handbook of Clinical Neurology","first-page":"51","article-title":"The humoral immune response to virus infection","volume":"56","author":"Sadiq","year":"1989"},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0060","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/j.1469-0691.2011.03653.x","article-title":"Progressive multifocal leukoencephalopathy: an unexpected complication of modern therapeutic monoclonal antibody therapies","volume":"17","author":"Tavazzi","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/ana.410310426","article-title":"Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy","volume":"31","author":"Tornatore","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0070","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","article-title":"Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort","volume":"78","author":"Trampe","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2013.05.009_bb0075","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","article-title":"Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy","volume":"354","author":"Yousry","year":"2006","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813001410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572813001410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:21:34Z","timestamp":1759047694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572813001410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":15,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0165572813001410"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.05.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid and serum JC virus antibody detection in multiple sclerosis patients treated with natalizumab","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2013.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}